Section 1c: FHIR®
Section 3: Implementation Guides
HL7 FHIR® Implementation Guide: Pharmaceutical Quality (Industry), Edition 1
DESCRIPTION
A universal realm FHIR Implementation Guide for standardized exchange of structured pharmaceutical quality data internationally within or between biopharmaceutical companies and their stakeholders.
ALTERNATIVE NAMES
HL7 FHIR® Implementation Guide: Pharmaceutical Quality (Industry), Edition 1 may also go by the following names or acronyms:
"HL7 FHIR® IG:dx-PQ, E1",Pharmaceutical Quality (Industry),PQ-Industry
BENEFITS
- Creates a common international standard to exchange product quality information across biopharmaceutical manufacturing organizations to facilitate technology transfer, allow enhanced monitoring of facilities, and support developing advanced manufacturing methodologies.
IMPLEMENTATIONS/CASE STUDIES
- Accumulus Synergy, Inc.
- Biopharmaceutical companies
RELATED DOCUMENTS
 |
HL7 FHIR® Implementation Guide: Pharmaceutical Quality (Industry), Edition 1 |
STU DOCUMENTS
|
HL7 FHIR® Implementation Guide: Pharmaceutical Quality (Industry), Edition 1 See the standard at http://hl7.org/fhir/uv/pharm-quality/STU1. | Expiration Apr 2026 |
TOPICS
- Laboratory
- Materials Management
- Pharmacy
- Regulated Products
BALLOT TYPE
- STU
STATUS DATE
2024-05-08RESPONSIBLE WORK GROUP
PRODUCT TYPE
- Implementation Guide
STAKEHOLDERS
- Equipment Vendors
- Lab Vendors
- Pharmaceutical Vendors
FAMILY
- FHIR
CURRENT STATE
- Active
REALM
- Universal